Ayrton Saunders is a speciality pharmaceutical company based in the UK focused on the development and commercialisation of aerosol based treatments and other high value niche products for international markets through collaboration and partnerships.
Since its foundation in 1868, Ayrton Saunders has strived to provide high-quality products and services to patients all over the world.
Ayrtons has a long history of supplying high quality products internationally to meet real patient needs. As an integral part of OBG, Ayrtons looks forward to a bright future by combining group resources, solid values and open minds, to build creative and opportunistic partnerships to bring high quality technology-based products to new markets.
